Risk Stratification of Sudden Cardiac Death in Patients with Heart Failure: An update

Risk Stratification of Sudden Cardiac Death in Patients with Heart Failure: An update

Heart failure (HF) is a complex clinical syndrome in which structural/functional myocardial abnormalities result in symptoms and signs of hypoperfusion and/or pulmonary or systemic congestion at rest or during exercise. More than 80% of deaths in patients with HF recognize a cardiovascular cause, wi...

Full description

Bibliographic Details
Main Authors:	Daniele Masarone, Giuseppe Limongelli, Ernesto Ammendola, Marina Verrengia, Rita Gravino, Giuseppe Pacileo
Format:	Article
Language:	English
Published:	MDPI AG 2018-11-01
Series:	Journal of Clinical Medicine
Subjects:	sudden cardiac death heart failure reduced ejection fraction heart failure preserved ejection fraction
Online Access:	https://www.mdpi.com/2077-0383/7/11/436

Similar Items

Beta Blockers Up-Titration in Patients with Heart Failure Reduced Ejection Fraction and Cardiac Resynchronization Therapy, a Single Center Study
by: Daniele Masarone, et al.
Published: (2019-06-01)

Heart failure with preserved ejection fraction: an update on pathophysiology, diagnosis, treatment, and prognosis
by: Chao Ma, et al.

Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides
by: Kaiyuan Zhu, et al.
Published: (2021-07-01)

Heart failure with mid‐range ejection fraction: pro and cons of the new classification of Heart Failure by European Society of Cardiology guidelines
by: Luca Branca, et al.
Published: (2020-04-01)

Heart Failure and Diabetes Mellitus: Biomarkers in Risk Stratification and Prognostication
by: Michael Lichtenauer, et al.
Published: (2021-05-01)

Central and Obstructive Apneas in Heart Failure With Reduced, Mid-Range and Preserved Ejection Fraction
by: Chiara Borrelli, et al.
Published: (2019-09-01)

Sirt1 Activity in PBMCs as a Biomarker of Different Heart Failure Phenotypes
by: Valeria Conti, et al.
Published: (2020-11-01)

Digoxin and Heart Failure: Are We Clear Yet?
by: Amit Gupta, MD, et al.
Published: (2017-05-01)

Improved cardiac and venous pressures during hospital stay in patients with acute heart failure: an echocardiography and biomarkers study
by: Eiichi Akiyama, et al.
Published: (2020-06-01)

The Use of β-Blockers in Heart Failure with Reduced Ejection Fraction
by: Daniele Masarone, et al.
Published: (2021-08-01)

Heart failure. The current state of the problem: achievements, frustrations, hopes and prospects
by: E. F. Pavlysh, et al.
Published: (2019-04-01)

Magnesium, Oxidative Stress, Inflammation, and Cardiovascular Disease
by: Man Liu, et al.
Published: (2020-09-01)

Effects of Sacubitril/Valsartan on the Right Ventricular Arterial Coupling in Patients with Heart Failure with Reduced Ejection Fraction
by: Daniele Masarone, et al.
Published: (2020-09-01)

Effect of aggressive diuresis in acute heart failure with reduced and preserved ejection fraction
by: Xin He, et al.
Published: (2021-08-01)

Combination therapy of midodrine and droxidopa for refractory hypotension in heart failure with preserved ejection fraction per a pharmacist’s proposal: a case report
by: Yuki Asai, et al.
Published: (2021-03-01)

Sex-Specific Relationship Between Parathyroid Hormone and Platelet Indices in Phenotypes of Heart Failure—Results From the MyoVasc Study
by: Bianca Dahlen, et al.
Published: (2021-06-01)

Differences in blood pressure riser pattern in patients with acute heart failure with reduced mid‐range and preserved ejection fraction
by: Tomoya Ueda, et al.
Published: (2019-10-01)

Cellular and Molecular Differences between HFpEF and HFrEF: A Step Ahead in an Improved Pathological Understanding
by: Steven J. Simmonds, et al.
Published: (2020-01-01)

Plasma levels of free fatty acid differ in patients with left ventricular preserved, mid-range, and reduced ejection fraction
by: Ning Zhu, et al.
Published: (2018-05-01)

Spotlight on Spironolactone Oral Suspension for the Treatment of Heart Failure: Focus on Patient Selection and Perspectives
by: Manolis AA, et al.
Published: (2019-12-01)

Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction
by: Susanne Jung, et al.
Published: (2021-04-01)

Sudden Cardiac Death in Patients with Heart Disease and Preserved Systolic Function: Current Options for Risk Stratification
by: Luigi Pannone, et al.
Published: (2021-04-01)

Impact of comorbidities in heart failure – prevalence, effect on functional status, and outcome in indian population: A single-center experience
by: Saurabh Mehrotra, et al.
Published: (2019-01-01)

Acute decompensated heart failure in a North Indian community hospital: Demographics, clinical characteristics, comorbidities and adherence to therapy
by: Sri Harsha Onteddu, et al.
Published: (2020-01-01)

Heart failure with preserved ejection fraction in elderly. From pathophysiology to treatment: an unresolved problem
by: Matteo Beltrami, et al.
Published: (2019-05-01)

Cardiorenal syndrome type 4: A study of cardiovascular diseases in chronic kidney disease
by: Suresh H., et al.
Published: (2017-01-01)

Phenotypic clusters in heart failure with preserved and mid-range ejection fraction: new data and perspectives
by: O. V. Tsygankova, et al.
Published: (2021-05-01)

Similarities and Differences Between HFmrEF and HFpEF
by: Peixin Li, et al.
Published: (2021-09-01)

Heart failure with preserved ejection fraction – new elements of evidence in the field of pathophysiology and new treatment options
by: Branimir Kanazirev
Published: (2021-07-01)

Heart failure with preserved ejection fraction: insights from recent clinical researches
by: Mi-Na Kim, et al.
Published: (2020-05-01)

Heart failure with preserved ejection fraction – onset
by: Branimir Kanazirev
Published: (2021-07-01)

Anaemia, iron deficiency and heart failure in 2020: facts and numbers
by: Vijay K. Chopra, et al.
Published: (2020-10-01)

Why majority of heart failure with preserved ejection fraction randomized controlled trials fail? Part: I
by: Satyanarayana Upadhyayula, et al.
Published: (2018-01-01)

The role of B-type natriuretic peptide in diagnosing acute decompensated heart failure in chronic kidney disease patients
by: Amer N. Kadri, et al.
Published: (2018-08-01)

Impact of diastolic dysfunction on outcome in heart failure patients with mid‐range or reduced ejection fraction
by: Dan Liu, et al.
Published: (2021-08-01)

Incidence and predictors of early and late sudden cardiac death in hospitalized Japanese patients with new‐onset systolic heart failure
by: Yoshiaki Minami, et al.
Published: (2021-10-01)

Osteopontin and LDLR Are Upregulated in Hearts of Sudden Cardiac Death Victims With Heart Failure With Preserved Ejection Fraction and Diabetes Mellitus
by: Mausam Patel, et al.
Published: (2020-11-01)

Factors associated with prolonged hospitalization, readmission, and death in elderly heart failure patients in western Romania
by: Gyalai-Korpos I, et al.
Published: (2015-03-01)

Prognostic role of anemia in heart failure with preserved ejection fraction: A systematic review and meta-analysis
by: Monil Majmundar, et al.
Published: (2021-07-01)

Impact of plasma xanthine oxidoreductase activity in patients with heart failure with preserved ejection fraction
by: Ken Watanabe, et al.
Published: (2020-08-01)